About this item:

688 Views | 305 Downloads

Author Notes:

Corresponding author. Mailing address: Dana-Farber Cancer Institute, JFB809, 44 Binney Street, Boston, MA 02115. Phone: (617) 632-3719. Fax: (617) 632-3112. E-mail: ruth_ruprecht@dfci.harvard.edu

We thank Hermann Katinger (Polymune Scientific, Vienna, Austria) for NMAbs 2G12, 2F5, and 4E10; Dennis Burton (Scripps Research Institute, La Jolla, CA) for CHO cells expressing IgG1b12; Barbara Felber (National Cancer Institute, Frederick, MD) for CEMx174-GFP cells; Susan Sharp for assistance in the preparation of the manuscript; Daniel Anderson for pathology support; and Stephanie Ehnert for coordinating sample collections.

We thank Tom Graf and Klemens Wassermann for help with the phylogenetic analysis.

Subjects:

Research Funding:

This work was supported by National Institutes of Health grants R01 DE012937, R01 DE016013, and R37 AI034266 to R.M.R.; HD39620, TW01429, and RR15635 to C.W.; P01 AI048240 to R.M.R., C.W., R.A.R., and R.D.G.; contract AI30034 to D.C.M.; and base grant RR-000165 to the Yerkes National Primate Research Center.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Virology

Neutralization-Sensitive R5-Tropic Simian-Human Immunodeficiency Virus SHIV-2873Nip, Which Carries env Isolated from an Infant with a Recent HIV Clade C Infection (vol 83, pg 1422, 2009)

Show all authors Show less authors

Tools:

Journal Title:

Journal of Virology

Volume:

Volume 83, Number 16

Publisher:

, Pages 8297-8297

Type of Work:

Article | Final Publisher PDF

Abstract:

Human immunodeficiency virus clade C (HIV-C) accounts for >56% of all HIV infections worldwide. To investigate vaccine safety and efficacy in nonhuman primates, a pathogenic, R5-tropic, neutralization-sensitive simian-human immunodeficiency virus (SHIV) carrying HIV-C env would be desirable. We have constructed SHIV-2873Ni, an R5-tropic SHIV carrying a primary pediatric HIV-C env gene isolated from a 2-month-old Zambian infant, who died within 1 year of birth. SHIV-2873Ni was constructed using SHIV-1157ipd3N4 (R. J. Song, A. L. Chenine, R. A. Rasmussen, C. R. Ruprecht, S. Mirshahidi, R. D. Grisson, W. Xu, J. B. Whitney, L. M. Goins, H. Ong, P. L. Li, E. Shai-Kobiler, T. Wang, C. M. McCann, H. Zhang, C. Wood, C. Kankasa, W. E. Secor, H. M. McClure, E. Strobert, J. G. Else, and R. M. Ruprecht. J. Virol. 80:8729-8738, 2006) as the backbone, since the latter contains additional NF-κB sites in the long terminal repeats to enhance viral replicative capacity. The parental virus, SHIV-2873Ni, was serially passaged through five rhesus monkeys (RMs); SHIV-2873Nip, the resulting passaged virus, was reisolated from the fourth recipient about 1 year postinoculation. SHIV-2873Nip was replication competent in RM peripheral blood mononuclear cells of all random donors tested and was exclusively R5 tropic, and its env gene clustered with HIV-C by phylogenetic analysis; its high sensitivity to neutralization led to classification as a tier 1 virus. Indian-origin RMs were inoculated by different mucosal routes, resulting in high peak viral RNA loads. Signs of virus-induced disease include depletion of gut CD4+ T lymphocytes, loss of memory T cells in blood, and thrombocytopenia that resulted in fatal cerebral hemorrhage. SHIV-2873Nip is a highly replication-competent, mucosally transmissible, pathogenic R5-tropic virus that will be useful to study viral pathogenesis and to assess the efficacy of immunogens targeting HIV-C Env.

Copyright information:

© 2009, American Society for Microbiology

Export to EndNote